REOPRO Side Effects

7012450-8 | Pulmonary Haemorrhage
on Sep 17, 2010 Male patient from UNITED STATES , 55 years of age, was diagnosed with percutaneous coronary intervention and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary haemorrhage. Reopro dosage: .

7005533-X | Alcohol Withdrawal Syndrome, Pulmonary Oedema
Patient was taking Reopro (View Usage). Patient had the following side effects: alcohol withdrawal syndrome, pulmonary oedema on Sep 10, 2010 from GERMANY Additional patient health information: Male patient , 38 years of age, was diagnosed with myocardial infarction and. Reopro dosage: . During the same period patient was treated with ABCIXIMAB (View Abciximab Review and Abciximab Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6999066-4 | Haemorrhage Intracranial
Adverse event was reported on Sep 13, 2010 by a Male patient taking Reopro (View Usage) (Dosage: ) . Location: UNITED STATES , 80 years of age, After Reopro was administered, patient had the following side effects: haemorrhage intracranial. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6972997-7 | Cardiogenic Shock
on Aug 30, 2010 Male patient from INDIA , 56 years of age, was diagnosed with angioplasty (What is angioplasty?) and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock. Reopro dosage: . Patient was hospitalized.


6939096-1 | Myocardial Infarction, Platelet Count Decreased, Respiratory Disorder
on Aug 13, 2010 Male patient from MEXICO , 58 years of age, was diagnosed with angina unstable and was treated with Reopro (View Usage). Patient had the following side effects: myocardial infarction, platelet count decreased, respiratory disorder. Reopro dosage: . Patient was hospitalized.

6936278-X | Cerebellar Haemorrhage, Cerebral Haemorrhage, Coronary Angioplasty
Patient was taking Reopro (View Usage). After Reopro was administered, patient had the following side effects: cerebellar haemorrhage, cerebral haemorrhage, coronary angioplasty on Aug 09, 2010 from NETHERLANDS Additional patient health information: Male patient , 77 years of age, was diagnosed with acute myocardial infarction, percutaneous coronary intervention and. Reopro dosage: . During the same period patient was treated with PRASUGREL (Loading Dose @00:00) (View Prasugrel Review and Prasugrel Label ), FONDAPARINUX SODIUM (View Fondaparinux Sodium Review and Fondaparinux Sodium Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6922237-X |
Adverse event was reported on Aug 03, 2010 by a Female patient taking Reopro (View Usage) (Dosage: ) . Location: INDIA , 68 years of age, . Patient was hospitalized.

6910355-1 | Intestinal Ischaemia
on Jul 27, 2010 Female patient from GERMANY , 90 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient had the following side effects: intestinal ischaemia. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6900718-2 | Atrial Flutter, Pneumonia, Renal Failure Acute
on Jul 23, 2010 Female patient from GERMANY , 72 years of age, was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: atrial flutter, pneumonia (What is pneumonia?), renal failure acute. Reopro dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), CORVATON (View Corvaton Review and Corvaton Label ).

6886895-0 | Myocardial Infarction
Patient was taking Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Jul 21, 2010 from FRANCE Additional patient health information: Female patient , 38 years of age, was diagnosed with coronary artery thrombosis and. Reopro dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CARDEGIC (View Cardegic Review and Cardegic Label ). Patient was hospitalized.

6879355-4 | Atrial Fibrillation, Cardiogenic Shock, Compartment Syndrome, Haemorrhage, Pneumonia, Pulmonary Embolism, Renal Failure, Respiratory Failure, Thrombocytopenia
Adverse event was reported on Jul 16, 2010 by a Male patient taking Reopro (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction and. Location: GERMANY , 71 years of age, weighting 260.1 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiogenic shock, compartment syndrome, haemorrhage, pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?), renal failure, respiratory failure, thrombocytopenia. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ).

6871010-X | Cardiogenic Shock, Electromechanical Dissociation, Myocardial Ischaemia, Pericardial Effusion, Ventricular Fibrillation
on Jul 15, 2010 Female patient from GERMANY , 75 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: cardiogenic shock, electromechanical dissociation, myocardial ischaemia, pericardial effusion, ventricular fibrillation. Reopro dosage: .

6867435-9 | Depressed Level Of Consciousness, Haemoglobin Decreased, Retroperitoneal Haematoma, Shock Haemorrhagic
on Jul 14, 2010 Female patient from GERMANY , 69 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, haemoglobin decreased, retroperitoneal haematoma, shock haemorrhagic. Reopro dosage: 11:57 To 11:59. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6867384-6 | Cerebrovascular Accident, Coronary Angioplasty
Patient was taking Reopro (View Usage). Patient had the following side effects: cerebrovascular accident, coronary angioplasty on Jul 13, 2010 from NETHERLANDS Additional patient health information: Male patient , 76 years of age, . Reopro dosage: . During the same period patient was treated with PRASUGREL (View Prasugrel Review and Prasugrel Label ). Patient was hospitalized.

6855777-2 | Angina Pectoris
Adverse event was reported on Jul 09, 2010 by a Female patient taking Reopro (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction and. Location: GERMANY , 74 years of age, After Reopro was administered, patient had the following side effects: angina pectoris. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ).

6848476-4 | Intestinal Ischaemia
on Jul 06, 2010 Female patient from GERMANY , 90 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal ischaemia. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6827088-2 | Coronary Artery Thrombosis, Underdose
on Jun 30, 2010 Male patient from UNITED KINGDOM , weighting 253.5 lb, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient had the following side effects: coronary artery thrombosis, underdose. Reopro dosage: .

6790325-7 | Pulmonary Haemorrhage
Patient was taking Reopro (View Usage). After Reopro was administered, patient had the following side effects: pulmonary haemorrhage on Jun 15, 2010 from AUSTRIA Additional patient health information: Male patient , 60 years of age, was diagnosed with acute myocardial infarction and. Reopro dosage: .

6784056-7 | Anaemia, Eosinophilia, Fat Embolism, Rash Macular, Skin Discolouration, Thrombocytopenia, Thrombosis In Device
Adverse event was reported on Jun 11, 2010 by a Female patient taking Reopro (View Usage) (Dosage: Infusion Over 18 Hours) was diagnosed with myocardial ischaemia, myocardial infarction and. Location: FRANCE , 45 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, eosinophilia, fat embolism, rash macular, skin discolouration, thrombocytopenia, thrombosis in device. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6774810-X | Cardiac Tamponade, Ventricle Rupture
on Jun 07, 2010 Female patient from GERMANY , 85 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient had the following side effects: cardiac tamponade, ventricle rupture. Reopro dosage: Infusion From 21:14 To 00:01. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6769276-X | Accidental Overdose
on Jun 03, 2010 Male patient from UNITED STATES , 34 years of age, was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: accidental overdose. Reopro dosage: .

6767245-7 | Overdose
Patient was taking Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: overdose on Jun 01, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with acute coronary syndrome and. Reopro dosage: 22.5 Ml. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).

6765309-5 | Pneumonia Aspiration, Septic Shock, Transaminases Increased
Adverse event was reported on Jun 01, 2010 by a Male patient taking Reopro (View Usage) (Dosage: ) was diagnosed with arteriogram coronary, pneumonia aspiration and. Location: FRANCE , weighting 205.0 lb, Patient had the following side effects: pneumonia aspiration, septic shock, transaminases increased. During the same period patient was treated with PRASUGREL (View Prasugrel Review and Prasugrel Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ).

6760009-X | Headache, Hyperhidrosis, Pyrexia
on May 28, 2010 Male patient from UNITED KINGDOM , 64 years of age, was diagnosed with coronary arterial stent insertion, prophylaxis against gastrointestinal ulcer and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: headache (What is headache?), hyperhidrosis, pyrexia. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6748675-6 | Ulcer Haemorrhage
on May 18, 2010 Male patient from UNITED STATES , 41 years of age, was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: ulcer haemorrhage. Reopro dosage: . During the same period patient was treated with PRASUGREL HYDROCHLORIDE (View Prasugrel Hydrochloride Review and Prasugrel Hydrochloride Label ).

6734192-6 | Cardiac Tamponade
Patient was taking Reopro (View Usage). Patient had the following side effects: cardiac tamponade on May 10, 2010 from AUSTRALIA Additional patient health information: Male patient , 83 years of age, . Reopro dosage: .

6729740-6 | Cardiac Tamponade, Ventricle Rupture
Adverse event was reported on May 06, 2010 by a Female patient taking Reopro (View Usage) (Dosage: Infusion From 21:14 To 00:01) was diagnosed with acute myocardial infarction and. Location: GERMANY , 85 years of age, After Reopro was administered, patient had the following side effects: cardiac tamponade, ventricle rupture. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6724828-8 | Ventricular Tachycardia
on May 04, 2010 Male patient from GERMANY , 66 years of age, was diagnosed with myocardial infarction and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular tachycardia. Reopro dosage: .

6721394-8 | Accidental Overdose, Product Label Confusion
on May 03, 2010 Male patient from FRANCE , 62 years of age, was diagnosed with acute coronary syndrome and was treated with Reopro (View Usage). Patient had the following side effects: accidental overdose, product label confusion. Reopro dosage: .

6719045-1 | Haemorrhagic Stroke
Patient was taking Reopro (View Usage). After Reopro was administered, patient had the following side effects: haemorrhagic stroke on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, was diagnosed with myocardial infarction and. Reopro dosage: . Patient was hospitalized and became disabled.

6710737-7 | Platelet Count Decreased
Adverse event was reported on May 04, 2010 by a Male patient taking Reopro (View Usage) (Dosage: 0.25mg/kg Bolus, 0.125 Mcg/kg/bolus, 0.125 Mcg/kg/min X 12 Hours Iv) was diagnosed with catheterisation cardiac, electrocardiogram st segment elevation and. Location: UNITED STATES , 73 years of age, weighting 152.1 lb, Patient experienced the following unwanted or unexpected effects: platelet count decreased. Patient was hospitalized.

6709066-7 | Cardiac Tamponade, Myocardial Rupture
on Apr 22, 2010 Female patient from GERMANY , 85 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient had the following side effects: cardiac tamponade, myocardial rupture. Reopro dosage: Infusion From 21:14 To 00:01. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6692826-9 | Cerebral Haemorrhage
on Apr 19, 2010 Male patient from GERMANY , 74 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: cerebral haemorrhage. Reopro dosage: 12 Hr Infusion, Stopped At 4 Hr. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6692815-4 | Cardiac Aneurysm, Cardiac Arrest, Cardiac Failure Congestive, Cerebrovascular Accident, Intracardiac Thrombus, Pleural Effusion, Pneumonia, Renal Failure Chronic, Ventricular Tachycardia
Patient was taking Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac aneurysm, cardiac arrest (What is cardiac arrest?), cardiac failure congestive, cerebrovascular accident, intracardiac thrombus, pleural effusion, pneumonia (What is pneumonia?), renal failure chronic, ventricular tachycardia on Apr 19, 2010 from GERMANY Additional patient health information: Male patient , 77 years of age, was diagnosed with myocardial infarction and. Reopro dosage: . During the same period patient was treated with ABCIXIMAB (View Abciximab Review and Abciximab Label ), CATECHOLAMINES (View Catecholamines Review and Catecholamines Label ). Patient was hospitalized.

6692802-6 | Cardiogenic Shock
Adverse event was reported on Apr 19, 2010 by a Female patient taking Reopro (View Usage) (Dosage: Bolus @10:31) was diagnosed with acute myocardial infarction and. Location: GERMANY , 82 years of age, Patient had the following side effects: cardiogenic shock.

6690099-4 | Retroperitoneal Haemorrhage
on Apr 12, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with catheterisation cardiac and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: retroperitoneal haemorrhage. Reopro dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6674976-6 | Cardiac Failure Congestive, Haematemesis, Renal Failure Acute
on Mar 31, 2010 Female patient from GERMANY , 82 years of age, was diagnosed with percutaneous coronary intervention, acute myocardial infarction and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, haematemesis, renal failure acute. Reopro dosage: Bolus From 20:12 To 20:13. Patient was hospitalized.

6646700-4 | Thrombocytopenia
Patient was taking Reopro (View Usage). Patient had the following side effects: thrombocytopenia on Mar 16, 2010 from GERMANY Additional patient health information: Male patient , weighting 200.4 lb, was diagnosed with percutaneous coronary intervention, acute myocardial infarction and. Reopro dosage: Bolus. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6645969-X | Cardiogenic Shock
Adverse event was reported on Mar 15, 2010 by a Female patient taking Reopro (View Usage) (Dosage: Bolus @10:31) was diagnosed with acute myocardial infarction and. Location: GERMANY , 82 years of age, After Reopro was administered, patient had the following side effects: cardiogenic shock.

6636612-4 | Cardiac Failure, Clostridial Infection, Pneumonia, Ventricular Septal Defect
on Mar 05, 2010 Male patient from GERMANY , 65 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, clostridial infection, pneumonia (What is pneumonia?), ventricular septal defect. Reopro dosage: Given At 22:13- 22:14. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6619462-4 | Pulmonary Haemorrhage, Pulmonary Oedema
on Feb 25, 2010 Male patient from CANADA , 60 years of age, was treated with Reopro (View Usage). Patient had the following side effects: pulmonary haemorrhage, pulmonary oedema. Reopro dosage: . Patient was hospitalized.

6615456-3 | Retroperitoneal Haemorrhage
Patient was taking Reopro (View Usage). After Reopro was administered, patient had the following side effects: retroperitoneal haemorrhage on Feb 22, 2010 from UNITED STATES Additional patient health information: Male patient , 37 years of age, was diagnosed with myocardial infarction and. Reopro dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6601292-0 | Cardiac Failure Congestive, Pulmonary Haemorrhage
Adverse event was reported on Feb 18, 2010 by a Male patient taking Reopro (View Usage) (Dosage: ) was diagnosed with percutaneous coronary intervention, myocardial infarction and. Location: SWEDEN , 42 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, pulmonary haemorrhage. Patient was hospitalized.

6600930-6 | Cardiac Failure Congestive, Pulmonary Haemorrhage
on Feb 18, 2010 Male patient from SWEDEN , 50 years of age, was diagnosed with percutaneous coronary intervention, acute myocardial infarction and was treated with Reopro (View Usage). Patient had the following side effects: cardiac failure congestive, pulmonary haemorrhage. Reopro dosage: . Patient was hospitalized.

6600929-X | Coronary Artery Thrombosis, Overdose, Puncture Site Haemorrhage, Subdural Haemorrhage
on Feb 16, 2010 Female patient from UNITED KINGDOM , 61 years of age, was diagnosed with angina pectoris, angioplasty (What is angioplasty?) and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: coronary artery thrombosis, overdose, puncture site haemorrhage, subdural haemorrhage. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6600665-X | Catheter Site Haemorrhage, Injection Site Haemorrhage, Thrombocytopenia
Patient was taking Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site haemorrhage, injection site haemorrhage, thrombocytopenia on Feb 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 187.5 lb, was diagnosed with catheterisation cardiac and. Reopro dosage: 30mg - 3 Vials-. During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), HUMALOG (View Humalog Review and Humalog Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

6590703-5 | Puncture Site Haemorrhage
Adverse event was reported on Feb 10, 2010 by a Female patient taking Reopro (View Usage) (Dosage: ) was diagnosed with acute coronary syndrome and. Location: GERMANY , 59 years of age, weighting 160.9 lb, Patient had the following side effects: puncture site haemorrhage. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PRASUGREL (View Prasugrel Review and Prasugrel Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6589937-5 | Acute Respiratory Distress Syndrome, Candidiasis, Cerebral Disorder, Pulmonary Haemorrhage, Respiratory Failure
on Feb 10, 2010 Male patient from SWEDEN , 56 years of age, was diagnosed with percutaneous coronary intervention, myocardial infarction and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: acute respiratory distress syndrome, candidiasis, cerebral disorder, pulmonary haemorrhage, respiratory failure. Reopro dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLEXANE (View Clexane Review and Clexane Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6589788-1 | Cardiogenic Shock
on Feb 08, 2010 Female patient from GERMANY , 82 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock. Reopro dosage: Bolus @10:31.

6580726-4 | Coronary Artery Thrombosis, Overdose, Puncture Site Haemorrhage, Subdural Haemorrhage
Patient was taking Reopro (View Usage). Patient had the following side effects: coronary artery thrombosis, overdose, puncture site haemorrhage, subdural haemorrhage on Feb 01, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 61 years of age, was diagnosed with angina pectoris, angioplasty (What is angioplasty?) and. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN SODIUM (3000 Df) (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.